A competitive inhibition enzyme immunoassay for the detection of Streptococcus pyogenes directly from throat specimens or from solid bacteriological medium is described. Group A-specific polysaccharide adsorbed onto treated polystyrene beads, in conjunction with rabbit antibody to S. pyogenes concentration of 1 g/6 ml and incubated overnight at 2 to 8°C. The pH of the solution was lowered to 2.0 with 1 N HCI and pepsin (Sigma Chemical Co., St. Louis, Mo.) added to a concentration of 0.5 mglml. The solution was mixed and incubated at 37°C for 2 h. After incubation, the solution was neutralized (pH 7.0) with 1 N NaOH, and the volume was increased to 10 ml with saline containing 0.2% Formalin. Finally, the suspension was diluted 1:10 with sterile saline containing 0.01% thimerosal for use in immunization.
Rapid methods of bacterial detection, which are not dependent on cell replication in culture, have gained popularity as a means of accelerating bacterial identification. Generally, latex agglutination and coagglutination are used after primary isolation for definitive identification (21, 28, 34) . Fluorescent antibody staining may be performed without primary isolation (26) , but it is time consuming and requires the use of specialized instrumentation.
Solid-phase immunoassays in which radioactive isotopes or enzymes are used (23, 36) combine ease of performance with sensitivity. Enzyme immunoassays (EIAs) have been used to detect respiratory tract microorganisms, including Staphylococcus aureus (20, 22) , Streptococcus pneumoniae (7), influenza A virus (3, 31) , and respiratory syncytial virus (5, 15, 30) . In this communication, we report a rapid and sensitive competitive inhibition EIA method for the detection of Streptococcus pyogenes antigen (group A polysaccharide antigen [APS] ) and demonstrate its clinical efficacy.
MATERIALS AND METHODS
Bacterial and viral strains. All bacterial and viral strains were obtained from the Abbott Laboratories culture collection, unless indicated otherwise.
Preparation of streptococcal vaccine. Streptococcal vaccine was prepared by the method of Lancefield (19) , with modifications. Beta-hemolytic S. pyogenes type 12 was grown in a carboy containing 12.5 liters of Todd-Hewitt broth (Difco Laboratories, Detroit, Mich.) plus 1.5 liters of a glucose-salts mixture (13) . The medium was inoculated with 70 ml of an 18-h broth culture and incubated at 37°C for 18 h. The cells were collected by centrifugation and washed three times with a lOx packed cell volume of 0.01 M phosphatebuffered saline (pH 7.2). The washed, packed cells were suspended in saline containing 0.2% Formalin at a final * Corresponding author.
concentration of 1 g/6 ml and incubated overnight at 2 to 8°C. The pH of the solution was lowered to 2.0 with 1 N HCI and pepsin (Sigma Chemical Co., St. Louis, Mo.) added to a concentration of 0.5 mglml. The solution was mixed and incubated at 37°C for 2 h. After incubation, the solution was neutralized (pH 7.0) with 1 N NaOH, and the volume was increased to 10 ml with saline containing 0.2% Formalin. Finally, the suspension was diluted 1:10 with sterile saline containing 0.01% thimerosal for use in immunization.
Antiserum. New Zealand White rabbits were immunized intravenously with the streptococcal vaccine as described by Lancefield (19) , with modifications. Briefly, injections of vaccine were given intravenously on 3 successive days for 3 weeks, with 0.25 ml for week 1, 0.50 ml for week 2, and 1.00 ml for week 3. Blood samples were taken at week 4. The 1.00-ml injections were continued until a suitable antibody response was obtained.
Preparation of APS. The group-specific polysaccharide from group A, beta-hemolytic streptococci type 12 was isolated and purified by the method of Fuller (11) as modified by Zittle and Harris (37) . The criteria for purity of the APS were a rhamnose content of 60 to 65% and no detectable protein or nucleic acid. Chemical analyses were determined colorimetrically or spectrophotometrically as described by Kabat and Mayer (16) . In addition to chemical purity, the APS was precipitated by antisera specific only for group A streptococci.
Conjugation of APS to BSA. The procedure for coupling APS to bovine serum albumin (BSA; fraction V; Sigma Chemical Co.) was performed by the method of Hirata et al. (14) , with modifications. A solution of 20 mg of APS in 2.4 ml of 0.1 M NaHCO3 was adjusted to pH 11.0 by the addition of 1.0 N NaOH. Twenty milligrams of cyanogen bromide in 1.2 ml of water was added, and the mixture was maintained at pH 11.0 by the addition of 1.0 N NaOH for 12 min. Ice was added to the reaction mixture to maintain the temperature at after which 17 mg of BSA in 3.0 ml of saline was added. The mixture was stirred for 20 h at 4°C and then dialyzed against distilled water for 20 h at 4°C. The resulting conjugate of APS and BSA was referred to as APS-BSA. The absorbance at 280 nm was measured to determine the protein content of APS-BSA; BSA was used as the standard.
Coating of polystyrene beads with APS-BSA. Adsorption of APS-BSA onto polystyrene beads was performed as follows. An optimal solution of APS-BSA which would result in a negative control value of 1.500 at 492 nm was prepared in 0.1 M sodium borate (pH 9.3). Beads were coated for 18 h at room temperature; they were then washed three times with an equal volume of 0.1 M sodium borate (pH 9.3). The beads were overcoated with a solution of 1% BSA in 0.1 M sodium borate (pH 9.3) for 3 h at room temperature, washed three times with 1% BSA in water, and dried under a stream of nitrogen.
Competitive inhibition EIA procedure. For each assay run, two positive controls, consisting of a known concentration of S. pyogenes type 12 (5 x 107 CFU/ml), and three negative controls were included. The negative controls contained a specimen dilution buffer which consisted of 0.1 M potassium phosphate (pH 6.5), 0.1% sodium lauryl sarcosinate (Sigma Chemical Co.), and 0.01% thimerosal. A 400-,u volume of control solutions or serial dilutions of S. pyogenes type 12 was incubated with 400 pul of a lytic enzyme (mucopeptidase; 75 ,ug/ml; Abbott Laboratories, North Chicago, Ill.) at 37°C for 30 min to expose the APS. A 400-pI volume of rabbit antiserum to S. pyogenes (0.16 pug/ml of immunoglobulin G) in a buffer, which consisted of 50% fetal calf serum (KC Biological, Lenexa, Kans.) in 0.025 M Tris (pH 7.2) containing 0.21% EDTA, 0.1% Tween 20, and 0.01% thimerosal, was added to each sample and incubated at 37°C for 60 min. Then, 200 pd of each sample was added to an antigen-coated bead, and the incubation was continued for 30 min. After the beads were washed three times with deionized water, 200 ,u1 of goat anti-rabbit globulin labeled with horseradish peroxidase (Kirkegaard and Perry Laboratories, Inc., Gaithersburg, Md.), diluted in a buffer which consisted of 45% fetal calf serum, 5% normal human serum (Abbott Laboratories), 0.1% Tween 20, and 0.01% thimerosal in 0.025 M Tris (pH 7.2), was added. The beads were incubated for 30 min at 37°C. After a final wash with deionized water, 300 p.1 of ophenylenediamine substrate (0.4 mg of o-phenylenediamine per ml in 0.15 M citrate-phosphate buffer [pH 5.5] containing 0.015% H202) was added per bead. Color development was allowed to take place for 30 min at room temperature and was terminated by the addition of 1.0 ml of 1.0 N H2SO4 per bead.
Spectrophotometric measurements were made at 492 nm. The percent inhibition value was determined by the following equation: [(negative control mean -unknown)/(negative control mean -positive control mean)] x 100 = percent inhibition.
Transport systems and swab fiber composition. Various transport systems and swabs of different fiber compositions (see Table 3 ) were seeded with 20 ,ul of stock solutions of S. pyogenes type 12 so that concentrations of 106, 105, 104, 103, and 102 CFU per swab were achieved. Swabs originating from transport systems were returned to their respective tubes and processed according to the instructions of the manufacturer. All swabs were assayed as described below.
Clinical specimens. Pharyngeal swabs were collected by a local pediatric group practice from children and adults with pharyngitis. Specimens were assayed by EIA, culture techniques incorporating bacitracin sensitivity, and, in the case of discordant results, capillary precipitin reactions. Therefore, before use in EIA, the swabs were streaked onto culture medium by laboratory personnel of the local pediatric group practice. Subsequently, the swabs were placed into plastic, screw-capped tubes, labeled, and sent to Abbott Laboratories. EIA was performed within 1 to 2 days of receipt of clinical specimens. Each swab was suspended in 400 p.1 of specimen dilution buffer and incubated with the lytic enzyme solution and rabbit antiserum to S. pyogenes as indicated previously. After these incubations, the swabs were removed, and any excess liquid was expressed by rotating the swab against the side of the tube. The assay procedure was continued with the bead incubation step as described above.
Sterile cotton swabs were used to pick single colonies of S. pyogenes, as well as other heterologous microorganisms, from blood agar plates which had been incubated for 18 to 24 h. Subsequently, swabs were used directly in the inhibition assay as described above.
Bacterial cultures. Bacterial cultures of clinical specimens were performed by the local pediatric group practice. For recovery of S. pyogenes from clinical specimens, swabs were streaked onto 5% sheep blood agar medium, and a 0.04-U bacitracin disk was placed over the area of heaviest inoculation. After 18 to 24 h at 37°C, the cultures were examined for the presence of S. pyogenes. S. pyogenes was identified by beta-hemolysis around typical colonies and by a zone of inhibition surrounding the bacitracin disk (10, 25) .
Serological identification for confirmation of culture. Discordant results were resolved by capillary precipitin analyses. Tests were performed with the Streptococcus Antisera Set (Difco Laboratories) according to the recommendations of the manufacturer. The autoclave method for the preparation of the antigen extract was used. RESULTS Sensitivity. Sensitivity of EIA was quantified by assaying serial dilutions of S. pyogenes. Figure 1 (Tables 1 and 2 ). The negative percent inhibitions could be attributed to variability of the bead coating. Some beads had more APS-BSA coated on the surface, resulting in the binding of more antibody.
Four strains of nonhemolytic S. pyogenes (a gift kindly provided by Wannamaker, University of Minnesota, Minneapolis) were tested at a concentration of 106 CFU per test.
Percent inhibitions obtained by the EIA were similar to the control value of 95% (Table 1) .
Effect of transport systems and swab fiber composition. The collection of throat specimens for culture often involves the use of a transport medium such as Stuart medium or ToddHewitt broth. The effects of these transport media are shown in Table 3 . Also, the effect of various swab fiber compositions on the performance of EIA was examined. Swabs which consisted of cotton, rayon, dacron, and calcium alginate were tested. The results (Table 3) indicate that the composition of the swab fibers had no effect on EIA activity for S. pyogenes.
Analysis of cutoff value. EIA was performed on 827 pharyngeal swabs. The data were analyzed and compared with culture results after resolution of discordant specimens (see below) to establish a cutoff value to discriminate between positive and negative specimens. Figure 2 is 13 EIA-negative culture-positive specimens, 6 were confirmed positive. Of the 38 EIA-positive, culture-negative specimens, 25 were confirmed positive. As a result, the actual number of true-positive specimens was 202, consisting of 184 culture-positive specimens plus 25 culture-negative specimens that were confirmed positive minus 7 culturepositive specimens that were confirmed negative (Table 4) . Likewise, the number of true-negative specimens was 625. This was obtained by adding the 7 culture-positive specimens that were confirmed negative (Table 4) to the 643 culture-negative specimens minus 25 culture-negative specimens that were confirmed positive (Table 4) . Therefore, 196 of the 202 culture, confirmed positive specimens were positive by EIA (97.0%) and 612 of the 625 culture, confirmed negative specimens were negative by EIA (97.9%) ( Table 5) .
Use of the EIA to identify colonies of S. pyogenes on blood agar plates. Multiple colonies of S. pyogenes, as well as other heterologous microorganisms, were picked from blood agar plates which had been incubated for 18 to 24 h. The results (Table 6) indicate that percent inhibitions obtained with all heterologous microorganisms tested were less than the cutoff of 40. All S. pyogenes colonies tested resulted in a percent inhibition of greater than 90. 
DISCUSSION
The most frequently used method of diagnosis for streptococcal pharyngitis involves isolation of S. pyogenes from throat swabs cultured on sheep blood agar (1, 10, 25) . The sensitivity of this method has been reported to be in the range of 80 to 95% (2) . For definitive identification of S. pyogenes, latex agglutination, coagglutination, and fluorescent antibody staining generally are used after primary isolation (8, 21, 28, 34, 35) . These techniques also have been used directly on clinical samples. Slifkin and Gil (33) Gerber (12) reported sensitivities of ca. 78% when nitrous acid extraction-coagglutination assays were used with pharnygeal swabs. Likewise, Edwards et al. (9) reported a sensitivity of 83.9% when a latex agglutination test was used (24) reported an 89% sensitivity with a latex system used directly on enzyme-digested throat swabs. Fluorescent-antibody staining, although theoretically providing the greatest sensitivity levels, requires trained personnel and the use of a fluorescence microscope and is often time consuming. ETAs offer an alternative to the above methods. Using this technology, Cumming and co-workers (6) developed an enzyme-linked immunosorbent assay that would identify colonies of S. pyogenes sampled from blood agar plates. Whereas this assay required an initial primary culture, the EIA described in the present communication was developed as a presumptive and confirmatory assay to be used directly on pharyngeal swabs. The EIA possesses greater sensitivity than those reported for latex agglutination and coagglutination. Calandra and Henson (4) reported that latex agglutination and coagglutination assay systems had sensitivities in the range of 104 CFU per test. In contrast, the EIA described in this communication could discriminate less than 104 CFU of S. pyogenes per test, depending upon the cutoff value selected. In addition to greater sensitivity, EIA could be used with various transport systems as well as with swabs of different fiber compositions. It should be noted, however, that evaluations of clinical specimens need to be performed to substantiate assay compatibilities.
Whereas EIA could discriminate S. pyogenes from background reactivity at cutoff values as low as 25%, a cutoff value of 40% was assigned to discriminate between positive and negative clinical specimens. Sensitivity and specificity were maximal at this value. When this cutoff value was used, the clinical sensitivity of the immunoassay was 97.0%. The 3.0% false-negative results may be due to specimens which contained an antigen load below the detection level of EIA. In addition, S. pyogenes may be nonreactive if antigenic determinants that are recognized in the test are masked by host factors. In vitro as well as in vivo studies have shown that immunoglobulin G and other serum proteins can absorb to the surface of streptococci (18, 27, 32) .
The specificity of the assay was 97.9%o. The basis of the false-positive reactions is not entirely clear. Colonies from subcultures of false-positive specimens were tested with EIA. All isolates yielded negative results. This is consistent with the observations made with purified microbial suspensions as well as by analyzing colonies directly from blood agar plates. Several possible explanations can be proposed. The cross-reacting microorganism may not grow on the blood agar plate. Another possibility is that the growth of S. pyogenes on the blood agar plate may be inhibited by the normal throat flora of the host (29 
